Twenty-five-year research progress in hookworm excretory/secretory products

AMI Abuzeid, X Zhou, Y Huang, G Li - Parasites & vectors, 2020 - Springer
Hookworm infection is a major public health problem that threatens about 500 million people
throughout tropical areas of the world. Adult hookworms survive for many years in the host …

Lessons along the critical path: developing vaccines against human helminths

DJ Diemert, ME Bottazzi, J Plieskatt, PJ Hotez… - Trends in …, 2018 - cell.com
Helminthic parasites are important targets for vaccine research as they infect an estimated 1
billion people worldwide. Despite significant progress in the discovery of defined antigens …

A phase 1 study of the safety, reactogenicity, and immunogenicity of a Schistosoma mansoni vaccine with or without glucopyranosyl lipid A aqueous formulation (GLA …

WA Keitel, GE Potter, D Diemert, J Bethony… - Vaccine, 2019 - Elsevier
Abstract Background Schistosomiasis caused by Schistosoma mansoni (Sm) is a chronic,
debilitating and potentially deadly neglected tropical disease. The licensure of a vaccine to …

[HTML][HTML] Human hookworm infection: is effective control possible? A review of hookworm control efforts and future directions

MS Haldeman, MS Nolan, KRN Ng'habi - Acta tropica, 2020 - Elsevier
Human hookworm, a soil-transmitted helminth (STH) infection caused by either Necator
americanus or Anclystoma duodenale, is a major cause of morbidity globally and …

[HTML][HTML] Clinical formulation development of Plasmodium falciparum malaria vaccine candidates based on Pfs48/45, Pfs230, and PfCSP

J Plieskatt, P Bang, GK Wood, M Naghizadeh… - Vaccine, 2024 - Elsevier
Two malaria transmission-blocking vaccine (TBV) candidates, R0. 6C and ProC6C, have
completed preclinical development including the selection of adjuvants, Alhydrogel® with or …

A Journey in Science: Molecular vaccines for global child health in troubled times of anti-science

PJ Hotez - Molecular Medicine, 2024 - Springer
My scientific life in translational medicine runs in two parallel, yet often converging paths.
The first, is four-decade-long commitment to develop new vaccines for parasitic and …

A highly expressed intestinal cysteine protease of Ancylostoma ceylanicum protects vaccinated hamsters from hookworm infection

JB Noon, EM Schwarz, GR Ostroff… - PLoS neglected tropical …, 2019 - journals.plos.org
Background Human hookworms (Necator americanus, Ancylostoma duodenale, and
Ancylostoma ceylanicum) are intestinal blood-feeding parasites that infect~ 500 million …

Establishing a controlled hookworm human infection (CHHI) model for Africa: A report from the stakeholders meeting held in Lambaréné, Gabon, November 10–11 …

A Alabi, M Hussain, MA Hoogerwerf… - Archives of Public …, 2021 - Springer
Background Hookworm is a major contributor to worldwide disease burden with over 230
million people infected. It has been identified as one of the Neglected Tropical Diseases that …

[HTML][HTML] Potency testing for a recombinant protein vaccine early in clinical development: Lessons from the Schistosoma mansoni Tetraspanin 2 vaccine

G Li, L Hoeweler, B Keegan, J Peng, L Scholte… - Vaccine: X, 2021 - Elsevier
Introduction As a primary stability-indicating parameter, potency should be strategically
evaluated during each phase of vaccine development. Herein, we present potency testing …

Genomic and transcriptomic profiling of nematode parasites surviving after vaccine exposure

G Sallé, R Laing, JA Cotton, K Maitland, A Martinelli… - bioRxiv, 2017 - biorxiv.org
Nematodes are economically important parasites of many livestock species, while others are
important human pathogens causing neglected tropical diseases. In both humans and …